Karl Penz, MBA, is an accomplished finance professional with extensive experience in the pharmaceutical industry. Currently serving as CFO of Boehringer Ingelheim's Innovation Unit and Group Functions since May 2009, Karl Penz is responsible for R&D Pipeline Strategy and Steering, R&D Controlling, and Investment Governance, alongside overseeing Group Functions such as IT, Finance, and Public Affairs. Prior roles include VP Corporate Controlling and Accounting, VP Process & Program Management, General Manager of Boehringer Israel, and Head of Treasury, Tax and Accounting at the Regional Center Vienna. Previous experience includes a position as a Senior Consultant at PwC Österreich. Karl Penz holds an Executive MBA from Henley Business School, a Steuerberater qualification from Kammer der Wirtschaftstreuhänder, and a Diploma in Business Economics from Universität Innsbruck.